A team of Australian high school students recreated a prime ingredient in the drug that Martin Shkreli's former company price-hiked to over $110,000, reports ABC News.
How much did it cost them? Well, $20.
The ingredient, called Pyrimethamine, is an active ingredient in Daraprim, which treats a parasitic infection that commonly occurs in people with weak immune systems, like pregnant women and HIV patients.
In August 2015, Turing Pharmaceuticals acquired the rights to Daraprim and hiked the price per tablet from $13.50 to a whopping $750.
This price hike inspired students at Sydney Grammar to try and create the drug cheaply. They worked with researchers at the University of Sydney via an online research-sharing platform called Open Source Malaria.
Many on social media are still upset with Shkreli for the price hike.
There's a chance Martin Shkreli gets a cabinet position, isn't there?— Jeremy Chao (@jmchao) November 20, 2016
Like, really upset.
For more, check out the 60 Second Circa.